Dignitana celebrates California law expanding scalp cooling coverage
AB 1682 mandates insurance coverage for FDA-cleared scalp cooling devices to reduce financial barriers for chemotherapy patients, effective January 1, 2027.
See the latest news and media coverage for Dignitana. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company providing scalp cooling for chemotherapy patients
dignitana.comLast updated
In short: Dignitana reported California coverage law, new CPT codes and FDA expansion, and delisted after Paxman takeover.
AB 1682 mandates insurance coverage for FDA-cleared scalp cooling devices to reduce financial barriers for chemotherapy patients, effective January 1, 2027.
HB 5374, signed into law, requires insurance coverage for scalp cooling from January 2027.
Paxman, holding over 90 percent of shares, initiated compulsory acquisition; the board resolved at its request to seek delisting.
Following Nasdaq Stockholm's decision, the last day of trading is 24 June 2025.
The cooling cap, manufactured by Sweden-based Dignitana, circulates cold liquid through a silicone cap that is worn on the head during treatment with chemotherapy. The...
HUDDERSFIELD, England, May 8, 2025 /PRNewswire/ -- The merger leverages Paxman's leading position in scalp cooling and combines the strengths of both organizations to drive...
THE OFFER IS NOT BEING MADE, AND THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, AND NO ACCEPTANCE FORMS WILL BE...
STOCKHOLM, Nov. 3, 2021 /PRNewswire/ -- Dignitana, world leader in scalp cooling innovation, announces that the U.S. Centers for Medicare & Medicaid Services (CMS) has...
Track Dignitana and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.